These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21793675)

  • 1. Nanomaterial cell interactions: are current in vitro tests reliable?
    Hirsch C; Roesslein M; Krug HF; Wick P
    Nanomedicine (Lond); 2011 Jul; 6(5):837-47. PubMed ID: 21793675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward.
    Lai DY
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):1-15. PubMed ID: 21965171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput toxicity screening and intracellular detection of nanomaterials.
    Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assessments of nanomaterial toxicity.
    Jones CF; Grainger DW
    Adv Drug Deliv Rev; 2009 Jun; 61(6):438-56. PubMed ID: 19383522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method to assess the quality of studies that examine the toxicity of engineered nanomaterials.
    Card JW; Magnuson BA
    Int J Toxicol; 2010 Jul; 29(4):402-10. PubMed ID: 20634541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative in vitro assays in nanomaterial toxicology.
    Hartung T; Sabbioni E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(6):545-73. PubMed ID: 21766468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials.
    Card JW; Jonaitis TS; Tafazoli S; Magnuson BA
    Crit Rev Toxicol; 2011 Jan; 41(1):22-49. PubMed ID: 21077788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity testing of nanomaterials.
    Schrand AM; Dai L; Schlager JJ; Hussain SM
    Adv Exp Med Biol; 2012; 745():58-75. PubMed ID: 22437813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multilevel approach for the evaluation of nanomaterials' toxicity.
    Galluzzi L; Chiarantini L; Pantucci E; Curci R; Merikhi J; Hummel H; Bachmann PK; Manuali E; Pezzotti G; Magnani M
    Nanomedicine (Lond); 2012 Mar; 7(3):393-409. PubMed ID: 22047028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity.
    Fako VE; Furgeson DY
    Adv Drug Deliv Rev; 2009 Jun; 61(6):478-86. PubMed ID: 19389433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive determination of cellular oxygen consumption as novel cytotoxicity assay for nanomaterials.
    Neumeyer A; Bukowski M; Veith M; Lehr CM; Daum N
    Nanotoxicology; 2014 Feb; 8(1):50-60. PubMed ID: 23134271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Understanding of Autophagy in Nanomaterial Toxicity and Its Implementation in Safety Assessment-Related Alternative Testing Strategies.
    Chen RJ; Chen YY; Liao MY; Lee YH; Chen ZY; Yan SJ; Yeh YL; Yang LX; Lee YL; Wu YH; Wang YJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.